Internal appointment at UK MHRA as Ian Hudson named new chief exec
This article was originally published in Scrip
Executive Summary
Ian Hudson has been named the new head of the UK Medicines and Healthcare Products Regulatory Agency. Dr Hudson, currently the MHRA’s licensing director, will succeed Professor Sir Kent Woods when the latter steps down in September after almost 10 years as chief executive of the agency. Dr Hudson is well-known in regulatory and industry circles. He is the UK delegate to the European Medicines Agency’s Committee on Human Medicinal Products (CHMP) and has been the committee’s vice-chairman since October 2012.